A combination of IgG and IgM autoantibodies in chronic cold agglutinin disease: immunologic studies and response to splenectomy.

Vox Sanguinis (Impact Factor: 3.3). 02/1985; 48(2):105-9. DOI: 10.1111/j.1423-0410.1985.tb00153.x
Source: PubMed

ABSTRACT A patient with chronic cold agglutinin disease and anti-I antibody was studied. The titer of the patient's serum at 4 degrees C was 700 with adult I RBC, 256 with cord RBC, 256 with adult i RBC. At room temperature the titers were decreased and the serum also reacted at a titer of 4,000 with enzyme treated adult I RBC. Dithiothreitol treatment of the serum and purified antibody decreased reactivity only slightly, indicating that the antibody was IgG. The heat eluate contained 1.2 mg/ml IgG kappa, but only 80 micrograms/ml IgM kappa. A hybridoma made by fusing the patient's peripheral blood lymphocytes with a human myeloma cell line contained only IgM kappa (30 micrograms/ml) anti-I activity. The IgM fraction of the heat eluate reacted similarly to the hybridoma supernatant. The IgG fraction resembled the serum and heat eluate. In this case study, IgG kappa and IgM kappa immunoglobulins, both possessing cold agglutinin activity, were present in the patient's serum. This finding is unusual in idiopathic cold agglutinin disease and in view of the predominance of an IgG cold agglutinin, splenectomy was recommended for treatment.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The technique of human-human (H + H) hybridoma is employed to generate human monoclonal antibodies. However, in contrast to mouse hybridomas, the human counterpart is very difficult to establish. It is still unclear what the precise reasons are for the failure to establish the human-human hybridoma technique as a routine. Analyses of HLA antigens of seven lymphocyte donors and 22 human cell lines generated by the H + H hybridoma technique have demonstrated the importance of the compatibility between human lymphocytes and the lymphoblastoid cell lines. Furthermore, there is a preferential expression of several HLA on human hybridomas (e.g. B51; B15; B18; B35). Screening several unrelated human lymphoblastoid cell lines available demonstrated preferred HLA antigens (A2, A3; A30/31; B5; B18; B15; B35), despite the fact that these lines were derived from subjects of different ethnic origins. It seems that HLA typing of donor lymphocytes and lymphoblastoid cell lines may help to increase the yield of H + H hybridomas.
    Tissue Antigens 11/1988; 32(4):209-14. · 2.35 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A monoclonal IgMK (IgMGAS) cold agglutinin (CA) of the infrequent anti-Gd specificity, found in a patient with Waldenström macroglobulinemia, has been characterized. IgMGAS uses a VH gene homologous (93.7%) to the reported VH251 germ-line, one of the two functional genes of the VH5 family, with differences in both framework regions and complementary determining regions (CDR). The VL gene is homologous to the reported 15AVK1 germ-line gene, recently described in an anti-i CA, with differences mostly clustered in CDR. In the patient's serum, IgMGAS coexisted with a monoclonal IgG3K (IgGGAS) that lacked CA activity but expressed the private idiotopes found on IgMGAS. Both Ig lacked reactivity with antibodies detecting VH1 or VHIII or VKIII subgroup regions or the VH4-21 gene product that is expressed by anti-I/i CAs. The K chains from both Igs showed the same isoelectrical mobility. Moreover, the k chains from both serum Igs showed the same N-terminal amino acid sequence. This sequence was identical to that predicted by the nucleotide sequence of VK1GAS gene segment, including one discrepancy at position 15 (Ile for Val) with respect to the consensus VK1 subgroup regions. Although these data do not exclude a possible independent clonal origin, they are consistent with the notion that IgGGAS might be clonally related to IgMGAS.
    Blood 04/1994; 83(5):1310-22. · 9.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 65-year-old white man had severe hemolytic anemia due to a mixture of low-titer IgG lambda and IgM lambda agglutinins showing optimum reactivity at 22 degrees C. The IgG agglutinins were detected by manual indirect antiglobulin test (IAT) using anti-IgG, and had a titer of 1 at 37 degrees C, 128 at 22 degrees C and 16 at 4 degrees C against adult type O red blood cells (RBC). The corresponding titers with cord RBC were 1 (37 degrees C), 64 (22 degrees C) and 8 (4 degrees C). Proteolytic enzyme and neuraminidase treatment of RBC did not decrease these titers. No known specificity could be assigned to these agglutinins. The isolated agglutinins (recovered by cold adsorption, warm elution) were shown by immunoelectrophoresis to be IgG lambda antibodies. They did not bind complement in vitro, consistent with the finding that the patient had negative manual direct antiglobulin test (DAT) by anti-C3d. It could be shown only by automated IAT that patient's serum also contained IgM cold agglutinins which also reacted best at 22 degrees C and appeared to be of lambda light-chain type. The patient responded to corticosteroid therapy and remains well without treatment 14 months after the hemolytic episode. The presence of IgG cold agglutinins may be predictive of a favorable response to corticosteroid therapy.
    Vox Sanguinis 02/1986; 51(2):112-6. · 3.30 Impact Factor